Skip to main content
SpringerLink
Log in

Atherosclerosis: the eicosanoid connection

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

This bird's eye view presents connections between the metabolically short-lived local hormones (collectively known as eicosanoids) and atherosclerotic cardiovascular disease. The discussion will be centered around an overview of coronary atherosclerosis with an emphasis on the sequences involved in the formation of atherosclerotic lesions; structure and historical background of oxygenated fatty acids cyclooxygenase and lipoxygenase products — eicosanoids; the generation of free radicals during the formation of endoperoxides by cyclooxygenase; the involvement of eicosanoids in the atherosclerotic inflammatory process, and finally, the effects of non-steroidal and steroidal anti-inflammatory drugs on the synthesis of eicosanoids and experimental atherosclerosis. Little is known about the exact role of eicosanoids in the genesis of atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wissler D: The evolution of the atherosclerotic plaque and its complications. In: WE Connor and JD Bristow (eds.) Coronary Heart Disease. J.B. Lippincott, New York, 1985, pp 193–214

    Google Scholar 

  2. Steinberg D: Current theories of the pathogenesis of atherosclerosis. In: D Steinberg and JM Olefsky (eds.) Hypercholesterolemia and atherosclerosis: Pathogenesis and Prevention. Churchill Livengstone, New York, 1987, pp 5–23

    Google Scholar 

  3. Goldblat MW: Properties of human seminal plasma. J Physiol 84: 208–218, 1935

    Google Scholar 

  4. Von Euler US: A depressor in the vesicular gland. J Physiol 84: 21, 1935

    Google Scholar 

  5. Bergstrom S, Sjovall J: The isolation of prostaglandins F and E from sheep prostate glands. Acta Chem Scan 14: 1693–1705,1960

    Google Scholar 

  6. Bergstrom S, Danielsson H, Samuelsson B: The enzymatic formation of prostaglandin E2 from arachidonic acid. Biochim Biophys Acta 90: 207–210, 1964

    Google Scholar 

  7. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: a new prostaglandin endoperoxides. Proc Nat Acad Sci 72: 2994–2998, 1975

    Google Scholar 

  8. Grylewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR: Arterial walls are protected against deposition of platelet thrombi by substance (prostacyclin) which they make from prostaglandin endoperoxides. Prostaglandins 12: 685–690, 1976

    Google Scholar 

  9. Samuelsson B, Borgeat P, Hammerstrom S, Murphy RC: Leukotrienes: A new group of biologically active compounds. In: B Samuelsson, P Ramwell and P Paoletti (eds.) Advances in prostaglandins and thromboxane Research. Raven press, New York, 1980, pp 1–18

    Google Scholar 

  10. Serhan CN, Hamberg M, Samuelsson B: Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Nat Acad Sci 81: 5335–5339, 1984

    Google Scholar 

  11. Munro JM, Cotran RS: The Pathogensis of Atherosclerosis: atherogenesis and inflammation. Lab Invest 58: 249–261, 1988

    Google Scholar 

  12. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW: The role of arachidonic acid oxygenation in pain and inflammation. Ann Rev Immunol 2: 335–357, 1984

    Google Scholar 

  13. Willis AL, Smith DL, Vigo C: Suppression of principal atherosclerotic mechanisms by prostaglandins and other eicosanoids. Prog Lipid Res 25: 645–666, 1986

    Google Scholar 

  14. Hajjar DP: Prostaglandins and eyelid nucleotides: Modulators of arterial cholesterol metabolism. Biochem Pharm 34: 295–300, 1985

    Google Scholar 

  15. Flier JS, Underhill LH: Pathogenesis and management of lipoprotein disorders. New Eng J Med 312: 1300–1310, 1985

    Google Scholar 

  16. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: A potential role in recuitment and retention of monocyte/macrophage during atherogenesis. Proc Nat Acad Sci 84: 2995–2998, 1987

    Google Scholar 

  17. Rankin SM, Parthsarathy S, Steinberg D: Evidence for a dominant role of lipoxygenases in the oxidation of LDL by a mouse peritoneal macrophages. J Lipid Res 32: 449–456, 1991

    Google Scholar 

  18. Spector AA, Gordon JA, Moore SA: Hydroxyeicosatetraenoic acids (HETES). Prog Lipid Res 27: 271–323, 1988

    Google Scholar 

  19. Korbut R, Zmuda A, Basista M, Gryglewski RJ: Eicosanoid balance at early stages of experimental atherosclerosis. Its relationship with plasma fibrinolytic activity and platelet aggregation. Agents Actions (Suppl.) 20: 225–236, 1986

    Google Scholar 

  20. Diez E, Fernandez B, Mortin C, Zamorano P, Schuller A: Acetylated low density lipoproteins promote the release and metabolism of arachidonic acid by murine macrophages. Biochem Biophy Res Comm 161: 461–467, 1989

    Google Scholar 

  21. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol.) 231: 232–235, 1971

    Google Scholar 

  22. Roth GJ, Siok CJ: Acetylation of the NH2-terminal serine of prostaglandin synthase by aspirin. J Biol Chem 253: 3782–3784, 1978

    Google Scholar 

  23. Flower RJ: Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharm 94: 987–1016, 1988

    Google Scholar 

  24. Bailey JM, Makheja AN, Pash J, Verma M: Corticosteroids suppress cyclooygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells. Bioc Biophy Res Comm 157: 1159–1163, 1989

    Google Scholar 

  25. Zurier RB: Prostaglandins, Inflammation, and Asthma. Arch Intern Med 133: 101–110, 1974

    Google Scholar 

  26. Hirosumi J, Nomoto A, Ohkulo Y, Sekiguchi C, Seitaro M, Yamaguchi I, Aoki H: Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis 64: 243–254, 1987

    Google Scholar 

  27. Bailey JM, Butler J: Anti-inflammatory drugs in experimental atherosclerosis — Relative potencies for inhibiting plaque formation. Atherosclerosis 17: 515–522, 1973

    Google Scholar 

  28. Makheja AN, Bloom S, Muesing R, Simon T, Bailey JM: Anti-inflammatory drugs in experimental atherosclerosis — Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate. Atherosclerosis 76: 377–386, 1989

    Google Scholar 

  29. Bailey JM, Makheja AN, Butler J, Salata K: Anti-inflammatory drugs in experimental atherosclerosis — Inhibition of Atherosclerosis in vivo and Thromboxane synthesis and Platelet Aggregation in vitro. Atherosclerosis 32: 195–203, 1979

    Google Scholar 

  30. Dhawan V, Ganguly NK, Majumdar S, Chakravarti RN: Short term therapy of atherosclerosis with low dose indomethacin: An experimental study. J Med Primatol USA 19: 663–673, 1990

    Google Scholar 

  31. The aspirin myocardial infarction study: Final results. The aspirin myocardial infarction study research group. Circulation (Suppl.) 62:79–84, 1980

  32. Parthasarathy S, Wieland E, Steinberg D: A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Nat Acad Sci 86: 1046–1050, 1989

    Google Scholar 

  33. Buchanan MR, Butt RW, Magas Z, Van Ryn J, Hirsh J, Nazir DJ: Endothelial cells produce a lipoxygenase derived chemorepellent which influence platelet/endothelial cell interactioneffect of aspirin and salicylate. Thromb Haemostasis 53: 306–311, 1985

    Google Scholar 

  34. Phan SH, McGarry BM, Loeffler KM, Kunkel SL: Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biology 42: 106–113, 1987

    Google Scholar 

  35. Palmberg L, Claesson H, Thyberg J: Effects of leukotrienes on phenotype properties and growth of arterial smooth muscle cells in primary culture. J Cell Sci 93: 403–408, 1989

    Google Scholar 

  36. Nashel DJ: Is atherosclerosis a complication of long-term corticoid treatment? Am J Med 80: 925–929, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Biochemistry and Molecular Biology, The George Washington University School of Medicine, 23001 Street, N.W., 20037, Washington, D.C., USA

    Amar N. Makheja

Authors
  1. Amar N. Makheja
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makheja, A.N. Atherosclerosis: the eicosanoid connection. Mol Cell Biochem 111, 137–142 (1992). https://doi.org/10.1007/BF00229585

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00229585

Key words

Search

Navigation